Evercore ISI lowered the firm’s price target on Cencora (COR) to $420 from $440 and keeps an Outperform rating on the shares. The 8% selloff in shares “looks overdone” as trends remain intact, the analyst tells investors in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COR:
- Cencora Earnings Call: Specialty Strength, Guidance Raised
- Cencora Completes OneOncology Acquisition, Lifts Guidance
- Cencora reports Q1 adjusted EPS $4.08, consensus $4.04
- Cencora backs FY26 adjusted EPS view $17.45-$17.75, consensus $17.59
- Cencora sees FY26 adjusted free cash flow about $3B; FY26 CapEx $900M